DENVER, CO — Patients at high risk of thromboembolism who require pacemaker or implantable cardioverter-defibrillator (ICD) surgery can safely remain onwarfarin, without interruption, rather than be ...

Houston, TX - Using enoxaparin or heparin to bridge long-term anticoagulation therapy with warfarin for secondary stroke prevention has been associated with a high risk for serious bleeding in ...

Many patients receiving an ICD or a pacemaker are already receiving oral anticoagulants. Current guidelines recommend replacement of the oral anticoagulant with the temporary use of heparin as a ...

Among patients with active cancer and acute symptomatic venous thromboembolism (VTE; blood clots in the deep veins), the use of the low molecular-weight heparin tinzaparin daily for 6 months compared ...

The common practice of administering heparin soon after cardioembolic stroke is associated with an increased risk for serious bleeding, according to an article in the Archives of Neurology. However, ...

Objectives: To compare the safety and effectiveness of two different thromboprophylactic protocols in the management of patients with spinal cord injury – one using heparin/warfarin and the other ...

low-dose subcutaneous heparin, although safer than warfarin, was ineffective for the prevention of venous thrombosis Given that low-dose subcutaneous heparin, although safer than warfarin, was ...

Following transradial coronary angiography, radial artery occlusion is more likely to occur in patients on chronic warfarin therapy but no parenteral anticoagulation compared with those receiving ...

Please provide your email address to receive an email when new articles are posted on . Venous thromboembolism causes substantial morbidity and mortality in patients with cancer. Patients with cancer ...

There is a common misconception that ischemic limb necrosis results only from thrombosis or thromboembolism involving limb arteries, with loss of arterial pulses. Yet ischemic limb gangrene can also ...

Among patients with active cancer and acute symptomatic venous thromboembolism (VTE; blood clots in the deep veins), the use of the low molecular-weight heparin tinzaparin daily for 6 months compared ...